Mentari Therapeutics Appoints Greg Divis as Chief Executive Officer
PRIVATEJul 20, 2026
Position
Chief Executive Officer
Company
Mentari Therapeutics
Greg Divis
San FranciscoBiotechnologyHealth CareTherapeutics
Description
Mentari Therapeutics, Inc. has announced the appointment of Greg Divis as Chief Executive Officer, effective July 20, 2026. Divis brings significant experience in strategic leadership and M&A expertise from his previous role as CEO of Avadel Pharmaceuticals.
Who to call at Mentari Therapeutics, and when
A new leader at Mentari Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Mentari Therapeutics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Mentari Therapeutics, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Mentari Therapeutics
Location
San Francisco, California, United States
About
Mentari Therapeutics is a biotechnology company developing therapies for the prevention of migraine to deliver freedom from this debilitating and undertreated neurological condition. Mentari's lead programs target PACAP, a newly validated target that is mechanistically independent from CGRP.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Mentari Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
San FranciscoBiotechnologyHealth CareTherapeutics